Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial (Q33655900)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

1

object named as

Yves Henrotin

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Myriam Gharbi

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Yvan Dierckxsens

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Fabian Priem

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Marc Marty

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Laurence Seidel

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Adelin Albert

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Elisabeth Heuse

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Valérie Bonnet

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Caroline Castermans

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

17 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

BMC Complementary and Alternative Medicine

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

159

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

17 May 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Curcumin reduces prostaglandin E2, matrix metalloproteinase-3 and proteoglycan release in the secretome of interleukin 1β-treated articular cartilage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Collagen catabolism through Coll2-1 and Coll2-1NO2 and myeloperoxidase activity in marathon runners

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Nutraceuticals: do they represent a new era in the management of osteoarthritis? – a narrative review from the lessons taken with five products

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Curcumin mediated suppression of nuclear factor-κB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Biological actions of curcumin on articular chondrocytes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Osteoarthritis: a tale of three tissues.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Multi-targeted therapy by curcumin: how spicy is it?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Curcumin as "Curecumin": from kitchen to clinic.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Type II collagen markers in osteoarthritis: what do they indicate?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Nutraceutical-definition and introduction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

21 June 2018

The pharmacology of curcumin: is it the degradation products?

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-14-159

21 January 2018

Collagen fibril disruption occurs early in primary guinea pig knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-14-159

21 January 2018

Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis -- results of a 1 year longitudinal arthroscopic study in 422 patients

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-14-159

21 January 2018

Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4032499

30 October 2018

Suppression of NF-κB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-14-159

21 January 2018

New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24886572

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-year follow-up of Coll2-1, Coll2-1NO2 and myeloperoxydase serum levels in osteoarthritis patients after hip or knee replacement

1 reference

https://pubmed.ncbi.nlm.nih.gov/24886572

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type II collagen peptides for measuring cartilage degradation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24886572

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coll2-1, Coll2-1NO2 and myeloperoxidase concentrations in the synovial fluid of equine tarsocrural joints affected with osteochondrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24886572

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coll2-1, Coll2-1NO2 and myeloperoxidase serum levels in erosive and non-erosive osteoarthritis of the hands

1 reference

https://pubmed.ncbi.nlm.nih.gov/24886572

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Usefulness of specific OA biomarkers, Coll2-1 and Coll2-1NO2, in the anterior cruciate ligament OA canine model

1 reference

https://pubmed.ncbi.nlm.nih.gov/24886572

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibulin 3 peptides Fib3-1 and Fib3-2 are potential biomarkers of osteoarthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24886572

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The chemical biomarkers C2C, Coll2-1, and Coll2-1NO2 provide complementary information on type II collagen catabolism in healthy and osteoarthritic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/24886572

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early decrease of serum biomarkers of type II collagen degradation (Coll2-1) and joint inflammation (Coll2-1 NO₂ ) by hyaluronic acid intra-articular injections in patients with knee osteoarthritis: a research study part of the Biovisco study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24886572

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1472-6882-14-159

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33655900&oldid=2195620318"